Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lignocaine Effect on Bupivacaine Spinal Blockade Duration
NCT01245868Phase 4Completed
- Sponsor
- Frederikssund Hospital
- Start
- Nov 2009
- Primary completion
- Dec 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of lidocaine in Knee joint disorder (KJD) (2 arms), sponsored by Frederikssund Hospital. Primary endpoint: Duration of spinal blockade at 360 minutes. Started Nov 2009; status: completed.
02
Drugs
lidocaine
03
Conditions
Knee joint disorder (KJD)
Beyond the preview
Go deeper on NCT01245868.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01245868.